Lice Treatment Market Share, Size, Trends, Industry Analysis Report, By Type (Pediculosis Capitis, Pediculosis Corporis, and Pediculosis Pubis); By Treatment; By Distribution Channel; By Region; Segment Forecast, 2024- 2032
- Published Date:Mar-2024
- Pages: 114
- Format: PDF
- Report ID: PM4798
- Base Year: 2023
- Historical Data: 2019-2022
Report Outlook
Global lice treatment market size was valued at USD 1,018.77 million in 2023. The market is anticipated to grow from USD 1,067.16 million in 2024 to USD 1,684.72 million by 2032, exhibiting the CAGR of 5.9% during the forecast period.
Market Overview
The rising incidence of lice infestations worldwide and growing awareness among people regarding the availability of lice treatments and its potential benefits, are key factors fostering the global market growth.
For instance, according to a report published by Centers for Disease Control and Prevention, around 6 million to 12 Mn cases of the head lice infestations take place each year in the United States in the children age 3 to 11 years, and the infestations are more often in girls than boys.
Head lice infestations are becoming very common issue especially among the children in school settings, thereby several awareness campaigns, initiatives, and educational programs being introduced by healthcare organizations to make people aware of the infestations and importance of their timely treatment.
To Understand More About this Research: Request a Free Sample Report
Growth Factors
Change in Lifestyles and Hygiene Practices to Drive Market Growth
There has been drastic change in people lifestyles such as changes in living standards and hygiene practices that contribute to the prevalence of lice and boosting the demand for effective treatment options. Also, factors such as growing travel and rapid pace of urbanizations especially in developing economies are also expected to result in higher incidences of lice, thereby propelling the market growth.
For instance, according to a report published by Urbanet, the urban population in India is currently stood at around 461 million and the number is growing at CAGR 2.3 percent. Also, it is estimated that the 75 percent country’s national income come from urban areas.
Increasing Number of Product Approvals by Regulatory Bodies to Spur Market Growth
The increase in the number of product approvals by leading regulatory authorities and agencies for the treatment of lice infestations and related issues, is anticipated to boost global market growth. Governments of several nations are mandating lice control measures in various settings including schools, healthcare facilities, and daycare centers, that foster the need for lice treatment products. For instance, according to a report by the Food and Drug Administration, they have approved several treatments for head lice including prescription drugs in shampoo, lotions, and cream rinse, and also non-prescription like OTC products.
Restraining Factors
High Cost of Treatments and Lack of Awareness to Restrain the Market Growth
The cost of lice treatments can be relatively high especially for families with low income and low awareness among people regarding the available treatment options and the importance of on-time effective treatment, are key factors expected to hamper the global market growth.
Report Segmentation
The market is primarily segmented based on type, treatment, distribution channel, and region.
|
By Type |
By Treatment |
By Distribution Channel |
By Region |
|
|
|
|
To Understand the Scope of this Report: Speak to Analyst
By Type Insights
Pediculosis Capitis Segment Accounted for the Largest Market Share in 2023
The pediculosis capitis segment accounted for the largest share. Segment’s dominance is attributed to greater prevalence of head lice infestations especially among school children and growing efforts to educate people about the importance of early detection of head lice detection and treatment. Additionally, growing advances and innovations in formulation technology that lead to the creation of new novel treatment options including lotions, shampoos, and combing devices, will further contribute to segment’s growth at significant pace.
By Treatment Insights
OTC Products Segment Held the Majority Revenue Share in 2023
The OTC products segment held the majority share. This dominance is due to various factors including increasing people spending time in several close contact settings and significant changes in lifestyles. Additionally, OTC products offer range of benefits to consumers such as providing a convenient and easily accessible treatment option at their home without the need of prescription and they are also more affordable over prescription treatments.
The prescription medications segment is expected to witness highest growth. This growth is accelerated by their higher effectiveness in treating head lice infestations as compared to OTC products when used according to the recommendation of healthcare professionals. In addition, prescription medications offer fast treatment and better compliance because they require very fewer applications and have shorter treatment duration, that is resulting in increased demand for these medications.
By Distribution Channel Insights
Hospital Pharmacies Segment will Grow at Highest Growth Rate During the Forecast Period
The hospital pharmacies segment will grow at highest growth rate. Segment’s growth is fueled by significant patient population in hospitals, easier access to prescription treatments, availability of healthcare professionals, and their collaboration with various delivery personnel in order to ensure that patients are receiving their medications conveniently.
The retail pharmacies segment led the market with largest revenue share. This dominance is driven by easy access to retail pharmacies for larger patient population, availability of wide range of lice treatment products like shampoos, combs, and creams. Moreover, there are several retail pharmacies focusing on the establishment of their online presence and providing medical products to their consumer through online channels to boost their sales and revenue, which will also foster the segment growth.
Regional Insights
North America Dominated the Global Market in 2023
The North America region dominated the global market with noteworthy share. Region’s dominance is attributed to presence of larger lice infestation patient pool and continuous increase in children population who are more susceptible to the disease. In addition, rising consumer disposable income especially in developed countries allowing consumers to spend higher on healthcare and afford expensive lice treatments like prescription options, is further escalating the product demand. For instance, according to the American Medical Association, health spending in the United States rose by nearly, 2.7% in 2021 to USD 4.3 trillion.
APAC expected to grow at the rapid pace. This growth is due to increasing awareness among people about the importance of early detection and treatment of head lice and growing availability of lice treatment products in pharmacies that is resulting in easier access to such medications. Moreover, continuous improvements in healthcare infrastructure across developing countries like India, China, Malaysia, and South Korea that led to greater access to advanced healthcare facilities and services, could also bode well for region’s growth.
Key Market Players & Competitive Insights
Strategic partnerships and product improvements to drive the competition
The lice treatment market is fragmented and is anticipated to witness competition due to several players' presence. Major companies are competing on various factors such as improving product efficacy, incorporating new active ingredients of formulations in treatment, strong marketing campaigns, and offering affordable price to the consumers. Also, companies are focusing on strategic partnerships and collaborations to expand their market presence and cater to wider customer base.
Some of the major players operating in the global market include:
- Arbor Pharmaceuticals LLC (US)
- Bayer AG (Germany)
- Insight Pharmaceuticals (US)
- Omega Pharma NV (Belgium)
- Parasol Laboratories (US)
- Pfizer Inc. (US)
- Prestige Brands Holding Inc. (US)
- Sanofi SA (France)
- Sumitomo Chemical Co. Ltd. (Japan)
- TAA Industries (Australia)
- TecLabs Inc. (US)
- Tyratech Inc. (US)
Recent Developments in the Industry
- In May 2023, The Australian Pesticides and Veterinary Medicines Authority, announced that the first oral lice treatment for sheep in the world is registered, and it is the first-of-its kind oral product that contains fluralaner for controlling lice in sheep. It includes strains resistant, synthetic pyrethroids, and several insect growth regulators on sheep as well as lambs.
Report Coverage
The lice treatment market report emphasizes on key regions across the globe to provide better understanding of the product to the users. Also, the report provides market insights into recent developments, trends and analyzes the technologies that are gaining traction around the globe. Furthermore, the report covers in-depth qualitative analysis pertaining to various paradigm shifts associated with the transformation of these solutions.
The report provides detailed analysis of the market while focusing on various key aspects such as competitive analysis, type, treatment, distribution channel, and their futuristic growth opportunities.
Lice Treatment Market Report Scope
|
Report Attributes |
Details |
|
Market size value in 2024 |
USD 1,067.16 million |
|
Revenue forecast in 2032 |
USD 1,684.72 million |
|
CAGR |
5.9% from 2024 – 2032 |
|
Base year |
2023 |
|
Historical data |
2019 – 2022 |
|
Forecast period |
2024 – 2032 |
|
Quantitative units |
Revenue in USD million and CAGR from 2024 to 2032 |
|
Segments covered |
|
|
Regional scope |
|
|
Competitive Landscape |
|
|
Report Format |
|
|
Customization |
Report customization as per your requirements with respect to countries, region, and segmentation. |
FAQ's
The global lice treatment market size is expected to reach USD 1,684.72 million by 2032
Key players in the market are Sumitomo Chemical, TecLabs, Omega Pharma, Bayer AG
North America contribute notably towards the global Lice Treatment Market
Lice treatment market exhibiting the CAGR of 5.9% during the forecast period.
The Lice Treatment Market report covering key segments are type, treatment, distribution channel, and region.
© 2024 Polaris Market Research and Consulting. All rights reserved
